RDF/XML JSON-LD N3/Turtle RDF/JSON
Author profile at the institutional portal

Quintela Fandiño, Miguel Angel miguel.quintela@uam.es

Medicina / Universidad Autónoma de Madrid

Publications

p27(Kip1) V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor-positive breast cancer

  • Mouron, S
  • Bueno, MJ
  • Munoz, M
  • Torres, R
  • Rodriguez, S
  • Apala, JV
  • Silva, J
  • Sanchez-Bayona, R
  • Manso, L
  • Guerra, J
  • Rodriguez-Lajusticia, L
  • Malon, D
  • Malumbres, M
  • Quintela-Fandino, M
... View more Collapse

Jnci Cancer Spectrum - 1/4/2023

10.1093/jncics/pkad014

  • ISSN 25155091
  • iMarina

When should we order a next generation sequencing test in a patient with cancer?

  • Colomer R, Mondejar R, Romero-Laorden N, Alfranca A, Sanchez-Madrid F, Quintela-Fandino M

Eclinicalmedicine (p. 100487-100487) - 1/8/2020

10.1016/j.eclinm.2020.100487 View at source

  • ISSN 25895370

Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

  • Hitt, R
  • Amador, ML
  • Quintela-Fandino, M
  • Jimeno, A
  • del Val, O
  • Hernando, S
  • Cortes-Funes, H;
... View more Collapse

Cancer (p. 106-111) - 1/1/2006

10.1002/cncr.21579 View at source

  • ISSN 0008543X

Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement

  • Colomer R
  • Miranda J
  • Romero-Laorden N
  • Hornedo J
  • González-Cortijo L
  • Mouron S
  • Bueno MJ
  • Mondéjar R
  • Quintela-Fandino M
... View more Collapse

Eclinicalmedicine - 1/6/2023

10.1016/j.eclinm.2023.102029 View at source

  • ISSN 25895370

Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer

  • Jimeno, R.
  • Mouron, S.
  • Salgado, R.
  • Loi, S.
  • Pérez-Mies, B.
  • Sánchez-Bayona, R.
  • Manso, L.
  • Martínez, M.
  • Garrido-García, A.
  • Serrano-Pardo, R.
  • Colomer, R.
  • Quintela-Fandino, M.
... View more Collapse

Clinical & Translational Oncology (p. 1124-1131) - 1/4/2023

Editor: Springer Science and Business Media Deutschland GmbH

10.1007/s12094-022-03006-3 View at source

  • ISSN 1699048X
  • ISSN/ISBN 1699-3055

Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer

  • Alvarez-Fernandez, Monica
  • Sanz-Flores, Maria
  • Sanz-Castillo, Belen
  • Salazar-Roa, Maria
  • Partida, David
  • Zapatero-Solana, Elisabet
  • Ali, H. Raza
  • Manchado, Eusebio
  • Lowe, Scott
  • VanArsdale, Todd
  • Shields, David
  • Caldas, Carlos
  • Quintela-Fandino, Miguel
  • Malumbres, Marcos;
... View more Collapse

Cell Death And Differentiation (p. 828-840) - 1/5/2018

10.1038/s41418-017-0024-0 View at source

  • ISSN 13509047

The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk

  • Arpaia, E.
  • Blaser, H.
  • Quintela-Fandino, M.
  • Duncan, G.
  • Leong, H. S.
  • Ablack, A.
  • Nambiar, S. C.
  • Lind, E. F.
  • Silvester, J.
  • Fleming, C. K.
  • Rufini, A.
  • Tusche, M. W.
  • Bruestle, A.
  • Ohashi, P. S.
  • Lewis, J. D.
  • Mak, T. W.;
... View more Collapse

Oncogene (p. 884-896) - 16/2/2012

10.1038/onc.2011.288 View at source

  • ISSN 09509232

Targeting the Tumor Stroma in Breast Cancer

  • Sanchez-Ruiz J
  • Quintela-Fandino M

Current Breast Cancer Reports (p. 71-79) - 28/3/2015

10.1007/s12609-014-0173-9 View at source

  • ISSN 19434596

Targeting cytoskeleton reorganisation as antimetastatic treatment

  • Quintela-Fandino, Miguel
  • Gonzalez-Martin, Antonio
  • Colomer, Ramon

Clinical & Translational Oncology (p. 662-669) - 1/10/2010

10.1007/s12094-010-0575-8 View at source

  • ISSN 1699048X

Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics

  • Navarro, P
  • Bueno, MJ
  • Zagorac, I
  • Mondejar, T
  • Sanchez, J
  • Mouron, S
  • Munoz, J
  • Gomez-Lopez, G
  • Jimenez-Renard, V
  • Mulero, F
  • Chandel, NS
  • Quintela-Fandino, M
... View more Collapse

Cell Reports (p. 2705-2718) - 21/6/2016

10.1016/j.celrep.2016.05.052 View at source

  • ISSN 22111247

This researcher has no books.

This researcher has no book chapters.

Phase I clinical trial of neoadjuvant BIBF1120 plus weekly paclitaxel (P) in early HER-2 negative breast cancer. CNIO-BR-01-2010 GEICAM 2010-10 study

  • Quintela-Fandino, M.
  • Urruticoechea, A.
  • Guerra, J.
  • Gil, M.
  • Gonzalez-Martin, A.
  • Marquez, R.
  • Hernandez-Agudo, E.
  • Rodriguez-Martin, C.
  • Gil, M.
  • Bratos, R.
  • Escudero, M. J.
  • Colomer, R.;
... View more Collapse

Cancer Research - 15/12/2013

10.1158/0008-5472.sabcs13-pd5-8 View at source

  • ISSN 00085472

This researcher has no working papers.

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3K?/?, in Patients with Advanced Solid Tumors

  • Choudhury AD, Higano CS, de Bono JS, Cook N, Rathkopf DE, Wisinski KB, Martin-Liberal J, Linch M, Heath EI, Baird RD, García-Carbacho J, Quintela-Fandino M, Barry ST, de Bruin EC, Colebrook S, Hawkins G, Klinowska T, Maroj B, Moorthy G, Mortimer PG, Moschetta M, Nikolaou M, Sainsbury L, Shapiro GI, Siu LL, Hansen AR

Clinical Cancer Research (p. 2257-2269) - 1/1/2022

10.1158/1078-0432.ccr-21-3087 View at source

  • ISSN 15573265

This researcher has no research projects.

Triple negative breast cancer kinome-taxonomy, prognostic and therapeutics: role of polynucleotide kinase-phosphatase

  • QUINTELA FANDIÑO, MIGUEL ANGEL (Director) Doctorando: Fernández Gaitero, Sara

4/3/2021

  • iMarina

This researcher has no patents or software licenses.

Last data update: 3/18/24 2:43 PM